Leukemia Clinical Trials

Find Leukemia Clinical Trials Near You

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Age ≥50 years

• A history of hematological malignancy

• Participants must be able to and willingly give informed consent

Locations
United States
Nebraska
University of Nebraska Medical Center
RECRUITING
Omaha
Contact Information
Primary
Taylor Johnson
taylora.johnson@unmc.edu
402-559-4596
Backup
IIT OFFICE
iitoffice@unmc.edu
402-559-4596
Time Frame
Start Date: 2026-04-09
Estimated Completion Date: 2033-03-25
Participants
Target number of participants: 180
Treatments
Experimental: Intervention Arm: Exercise + Behavioral Coaching
Intervention arm incorporating virtually supervised moderate-intensity aerobic exercise and behavioral intervention/coaching to improve adherence
Active_comparator: Enhanced Usual Care-Virtual Gym
Participants will receive access to a virtual exercise platform, and educational sessions but will not receive behavioral coaching
Sponsors
Leads: University of Nebraska

This content was sourced from clinicaltrials.gov